Sign Up to like & get
recommendations!
0
Published in 2020 at "Neoplasma"
DOI: 10.4149/neo_2020_200301n212
Abstract: In the post-Imatinib era, the median survival of patients diagnosed with GIST has reached almost 5 years. Prolonging GIST-specific survival, GIST patients have an increased incidence of secondary neoplasia. Data on the prognostic impact of…
read more here.
Keywords:
monocentric analysis;
second primary;
retrospective monocentric;
gist ... See more keywords